Coronavirus: UP’s first COVID-19 patient to undergo plasma therapy stable, say doctors

By: |
Updated: May 08, 2020 3:05 PM

 The patient from Orai in Uttar Pradesh was admitted to the King George Medical University (KGMU) in Lucknow on April 26.

Coronavirus, Coronavirus in UP, covid 19,covid 19 cases in UP, plasma therapy,latest news on coronavirus outbreakThis therapy uses antibodies from the blood of a cured coronavirus patient to treat another critical patient. (Representational image: Reuters)

A 58-year-old doctor, the first COVID-19 patient in Uttar Pradesh to undergo plasma therapy, is stable and continues to be on ventilator support 13 days after the experimental treatment began, doctors said on Friday. The patient from Orai in Uttar Pradesh was admitted to the King George Medical University (KGMU) in Lucknow on April 26.

“After 13 days, the condition of the patient is stable and he is still on ventilator. We can’t say when he will be discharged,” KGMU Vice Chancellor M L B Bhatt said. Dr Tulika Chandra of Blood Transfusion department, KGMU said, “When the patient was given plasma therapy his condition was very bad. Now his lungs have improved. But as he is old and has diabetes, he has been kept on ventilator. A team of doctors are keeping an eye on him.”

The patient was administered plasma donated by a doctor from Canada who was the first COVID-19 patient admitted to KGMU and later recovered.

Also read| Check Coronavirus latest updates here:

Convalescent plasma therapy is an experimental procedure for COVID-19 patients. In this treatment, plasma, a blood component, from a cured patient is transfused to a critically ill coronavirus patient.

The blood of a person who has recovered from COVID-19 develops antibodies to fight the virus. This therapy uses antibodies from the blood of a cured coronavirus patient to treat another critical patient.

The process of donating plasma is similar to that of donating blood and takes about an hour.

Union health ministry had advised against considering plasma therapy to be regular treatment for coronavirus and said that it should be used for research and trial purposes till there’s robust scientific evidence to support its efficacy.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Cancer researchers discover new organ in throat: What it is? How it can help in better treatment
2Asymptomatic children have low coronavirus levels compared to those with symptoms, study finds
3Coronavirus India update: Active Covid-19 caseload dips below 7-lakh mark for first time in 2 months